Courage Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$489K Hold
2,000
0.69% 14
2025
Q4
$414K Hold
2,000
0.57% 13
2025
Q3
$371K Hold
2,000
0.49% 14
2025
Q2
$306K Hold
2,000
0.45% 13
2025
Q1
$332K Hold
2,000
0.68% 12
2024
Q4
$289K Hold
2,000
0.6% 12
2024
Q3
$324K Hold
2,000
0.8% 11
2024
Q2
$292K Hold
2,000
0.74% 12
2024
Q1
$316K Hold
2,000
0.92% 12
2023
Q4
$313K Hold
2,000
1.26% 10
2023
Q3
$312K Hold
2,000
1.06% 10
2023
Q2
$331K Hold
2,000
0.91% 14
2023
Q1
$310K Hold
2,000
0.74% 15
2022
Q4
$353K Hold
2,000
0.99% 14
2022
Q3
$327K Hold
2,000
0.71% 15
2022
Q2
$355K Hold
2,000
0.58% 19
2022
Q1
$354K Hold
2,000
0.34% 29
2021
Q4
$342K Hold
2,000
0.23% 33
2021
Q3
$323K Hold
2,000
0.17% 38
2021
Q2
$329K Hold
2,000
0.2% 35
2021
Q1
$329K Hold
2,000
0.24% 35
2020
Q4
$315K Hold
2,000
0.31% 32
2020
Q3
$298K Buy
+2,000
New +$296K 0.33% 31
2020
Q2
Sell
-2,000
Closed -$262K 27
2020
Q1
$262K Buy
+2,000
New +$284K 0.59% 24

Other funds holding JNJ

Courage Capital Management's JNJ Position: Q1 2026 in Review

Courage Capital Management held its Johnson & Johnson (JNJ) position steady in Q1 2026 at 2,000 shares worth $489K. The position accounts for 0.69% of the portfolio, ranked #14.

Courage Capital Management first reported a position in JNJ in Q1 2020 and has held it in 24 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Courage Capital Management held 2,000 shares of Johnson & Johnson worth $489K as of Q1 2026.
  • Courage Capital Management left its Johnson & Johnson share count unchanged in Q1 2026.
  • Johnson & Johnson made up 0.69% of Courage Capital Management's portfolio in Q1 2026, its #14 holding.
  • Courage Capital Management first reported a position in Johnson & Johnson in Q1 2020 and has held it in 24 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Courage Capital Management's 13F filing for Q1 2026, filed 14 May 2026.